Clara Lam

543 total citations
20 papers, 339 citations indexed

About

Clara Lam is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Clara Lam has authored 20 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Clara Lam's work include Advanced Breast Cancer Therapies (5 papers), Economic and Financial Impacts of Cancer (4 papers) and Acute Myeloid Leukemia Research (3 papers). Clara Lam is often cited by papers focused on Advanced Breast Cancer Therapies (5 papers), Economic and Financial Impacts of Cancer (4 papers) and Acute Myeloid Leukemia Research (3 papers). Clara Lam collaborates with scholars based in United States, United Kingdom and Japan. Clara Lam's co-authors include Martha S. Linet, Amy Berrington de González, Meredith S. Shiels, Diana R. Withrow, Rochelle E. Curtis, Margaret A. Tucker, Lindsay M. Morton, Graça M. Dores, Sara J. Schonfeld and Byron Sigel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Clara Lam

19 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clara Lam United States 8 127 75 59 55 54 20 339
Kerstin L. Edlefsen United States 11 168 1.3× 22 0.3× 35 0.6× 32 0.6× 58 1.1× 23 365
Kristín Bjarnadóttir Iceland 5 166 1.3× 35 0.5× 54 0.9× 54 1.0× 35 0.6× 8 335
P. J. Loehrer United States 9 227 1.8× 143 1.9× 136 2.3× 43 0.8× 42 0.8× 18 603
Haiqing Ma China 12 145 1.1× 91 1.2× 56 0.9× 27 0.5× 6 0.1× 13 518
Michelle Purdom United States 7 129 1.0× 48 0.6× 11 0.2× 29 0.5× 71 1.3× 13 293
Vittorio Fregoni Italy 11 157 1.2× 18 0.2× 28 0.5× 173 3.1× 103 1.9× 23 383
Rebecca S. Tidwell United States 11 351 2.8× 19 0.3× 51 0.9× 111 2.0× 46 0.9× 40 617
Zsófia Miltényi Hungary 10 118 0.9× 18 0.2× 24 0.4× 19 0.3× 41 0.8× 50 292
Mariana L. Zahurak United States 11 112 0.9× 12 0.2× 20 0.3× 69 1.3× 20 0.4× 14 496
Ekkehard Eigendorff Germany 10 103 0.8× 25 0.3× 12 0.2× 226 4.1× 190 3.5× 19 416

Countries citing papers authored by Clara Lam

Since Specialization
Citations

This map shows the geographic impact of Clara Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Lam more than expected).

Fields of papers citing papers by Clara Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Lam. The network helps show where Clara Lam may publish in the future.

Co-authorship network of co-authors of Clara Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Clara Lam. A scholar is included among the top collaborators of Clara Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clara Lam. Clara Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Chia Jie, Anindit Chhibber, Clara Lam, et al.. (2024). Patient characteristics and treatment patterns of patients with locally advanced or metastatic HER2-low breast cancer, a single site descriptive study. Breast Cancer Research and Treatment. 208(3). 619–630.
2.
Lu, Yichen, et al.. (2024). Testing patterns and prevalence of PIK3CA, AKT1, and PTEN alterations among patients (pts) with HR+/HER2- metastatic breast cancer (mBC) in the US.. Journal of Clinical Oncology. 42(16_suppl). 1041–1041. 1 indexed citations
3.
Lam, Clara, Della Varghese, Beth Nordstrom, et al.. (2023). Abstract P4-03-34: Treatment Patterns and Associated Outcomes Among Patients with HER2+ Metastatic Breast Cancer in the United States. Cancer Research. 83(5_Supplement). P4–3. 1 indexed citations
4.
Mehta, Sandhya, et al.. (2023). The impact of metastatic breast cancer (mBC) treatment on patient reported productivity loss among patients with HER2+ mBC in the U.S.. JCO Oncology Practice. 19(11_suppl). 352–352. 1 indexed citations
5.
Noone, Anne‐Michelle, Clara Lam, Matthew E. Nielsen, et al.. (2021). Machine Learning Methods to Identify Missed Cases of Bladder Cancer in Population-Based Registries. JCO Clinical Cancer Informatics. 5(5). 641–653. 3 indexed citations
6.
Lam, Clara, et al.. (2020). Estimating Chemotherapy Use Among Patients With a Prior Primary Cancer Diagnosis Using SEER-Medicare Data. JNCI Monographs. 2020(55). 14–21. 2 indexed citations
7.
Jain, Anshu, Sanjay Aneja, Clifton D. Fuller, et al.. (2020). Provider Engagement in Radiation Oncology Data Science: Workshop Report. JCO Clinical Cancer Informatics. 4(4). 700–710. 3 indexed citations
8.
Rivera, Donna R., Timothy S. McNeel, Sean Brennan, et al.. (2020). Utilization of the Cancer Medications Enquiry Database (CanMED)-National Drug Codes (NDC): Assessment of Systemic Breast Cancer Treatment Patterns. JNCI Monographs. 2020(55). 46–52. 4 indexed citations
9.
Bernier, Marie‐Odile, Diana R. Withrow, Amy Berrington de González, et al.. (2019). Trends in pediatric thyroid cancer incidence in the United States, 1998‐2013. Cancer. 125(14). 2497–2505. 85 indexed citations
10.
Bremner, Karen E., K. Robin Yabroff, Diarmuid Coughlan, et al.. (2019). Patterns of Care and Costs for Older Patients With Colorectal Cancer at the End of Life: Descriptive Study of the United States and Canada. JCO Oncology Practice. 16(1). e1–e18. 9 indexed citations
11.
Lam, Clara, Joan L. Warren, Angela B. Smith, et al.. (2019). Using the SEER-Medicare Data to Assess Incident Chronic Myeloid Leukemia and Bladder Cancer Cases Missed by Cancer Registries. JNCI Monographs. 2020(55). 31–38. 4 indexed citations
12.
Rivera, Donna R., Clara Lam, Lindsey Enewold, et al.. (2019). Development and Utility of the Observational Research in Oncology Toolbox: Cancer Medications Enquiry Database-Healthcare Common Procedure Coding System (HCPCS). JNCI Monographs. 2020(55). 39–45. 9 indexed citations
13.
Withrow, Diana R., Amy Berrington de González, Clara Lam, Katherine E. Warren, & Meredith S. Shiels. (2018). Trends in Pediatric Central Nervous System Tumor Incidence in the United States, 1998–2013. Cancer Epidemiology Biomarkers & Prevention. 28(3). 522–530. 29 indexed citations
14.
Morton, Lindsay M., Graça M. Dores, Sara J. Schonfeld, et al.. (2018). Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era. JAMA Oncology. 5(3). 318–318. 119 indexed citations
15.
Lam, Clara, Kathleen A. Cronin, Rachel Ballard, & Angela B. Mariotto. (2018). Differences in cancer survival among white and black cancer patients by presence of diabetes mellitus: Estimations based on SEER‐Medicare‐linked data resource. Cancer Medicine. 7(7). 3434–3444. 13 indexed citations
16.
Ehrenkranz, Rebecca, et al.. (2018). Quality Assessment of Tumor Size Data Collection for Pancreatic and Breast Cancer in SEER.. PubMed. 45(4). 161–166. 1 indexed citations
17.
Coyle, Linda, Kathleen A. Cronin, Clara Lam, et al.. (2016). Validation of prostate‐specific antigen laboratory values recorded in Surveillance, Epidemiology, and End Results registries. Cancer. 123(4). 697–703. 26 indexed citations
18.
Morton, Lindsay M., Graça M. Dores, Meredith S. Shiels, et al.. (2015). Emerging Risks of AML/MDS and Other Myeloid Neoplasms Following Chemotherapy for First Primary Malignancy, 2000-2012. Blood. 126(23). 562–562. 1 indexed citations
19.
Lam, Clara, Rochelle E. Curtis, Graça M. Dores, et al.. (2015). Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma. Journal of Clinical Oncology. 33(28). 3096–3104. 27 indexed citations
20.
Lam, Clara, Rochelle E. Curtis, Graça M. Dores, et al.. (2015). Abstract LB-184: Risk factors for lung cancer among survivors of non-Hodgkin lymphoma. Cancer Research. 75(15_Supplement). LB–184. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kerstin L. Edlefsen Breakdown of academic impact, for papers by Kristín Bjarnadóttir Breakdown of academic impact, for papers by P. J. Loehrer Breakdown of academic impact, for papers by Haiqing Ma Breakdown of academic impact, for papers by Michelle Purdom Breakdown of academic impact, for papers by Vittorio Fregoni Breakdown of academic impact, for papers by Rebecca S. Tidwell Breakdown of academic impact, for papers by Zsófia Miltényi Breakdown of academic impact, for papers by Mariana L. Zahurak Breakdown of academic impact, for papers by Ekkehard Eigendorff
Rankless by CCL
2026